Table 1.

Descriptive statistics for patients from whom serum samples were collected. There were no significant differences between patients with PCOS and non-PCOS patients in terms of age, BMI, day 3 FSH, or estradiol, or progesterone. Patients with PCOS had higher baseline luteinizing hormone (LH) (8.2 vs 5.7 mIU/mL; p < 0.05), anti-Mullerian hormone (AMH) (12.5 vs 2.5 ng/mL; p = 0.001) and total testosterone (51.3 vs 21.4 ng/dL; p < 0.01)

	PCOS (n = 16)	Male or tubal (n = 19)	p-value
Age (years)	33.3 ± 1.2	35.2 ± 1.2	0.30
BMI (kg/m2)	28.3 ± 1.6	29.3 ± 1.1	0.56
FSH (mIU/mL)	6.2 ± 0.5	6.1 ± 0.6	0.82
LH (mIU/mL)	8.2 ± 1.4	5.7 ± 0.8	0.04*
Estradiol (pg/mL)	41.1 ± 8.4	30.5 ± 4.4	0.08
Progesterone (ng/mL)	0.3 ± 0.1	0.37 ± 0.1	0.70
Testosterone (ng/dL)	51.3 ± 26.5	21.4 ± 5.4	0.01**